Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper?
D002312:Cardiomyopathy, Hypertrophic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism*; D002352:Carrier Proteins; D004452:Echocardiography; D004562:Electrocardiography; D017809:Fatal Outcome; D005260:Female; D005500:Follow-Up Studies; D006639:Histidine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D007279:Injections, Subcutaneous; D019344:Lactic Acid / Q000097:blood; D008928:Mitochondria / Q000378:metabolism*; D024101:Mitochondrial Proteins; D018832:Molecular Chaperones; D009154:Mutation; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D011506:Proteins / Q000235:genetics*; D012074:Remission Induction
D002352:Carrier Proteins; D024101:Mitochondrial Proteins; D018832:Molecular Chaperones; D009942:Organometallic Compounds; D011506:Proteins; C400285:SCO2 protein, human; D019344:Lactic Acid; D006639:Histidine; C098468:copper histidine